查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999216

病毒學檢體採集市場​​：檢體類型、技術、疾病類型、最終用戶和通路分類－2026-2032年全球市場預測

Virology Specimen Collection Market by Sample Type, Technology, Disease Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，病毒學檢體採集市場​​價值將達到 41.3 億美元，到 2026 年將成長至 51.4 億美元，到 2032 年將達到 198.2 億美元，複合年成長率為 25.11%。

主要市場統計數據
基準年 2025 41.3億美元
預計年份：2026年 51.4億美元
預測年份 2032 198.2億美元
複合年成長率 (%) 25.11%

對影響醫療保健系統中現代病毒學檢體採集實踐的技術、臨床和操作促進因素進行了權威概述。

病毒學檢體採集的現況對診斷的準確性、調查的可靠性以及應對力至關重要。本文概述了影響檢體採集實踐的核心要素，包括技術方法、檢體類型、臨床路徑以及優先考慮檢體完整性的最終用戶。在監管環境不斷變化以及對快速可靠診斷的需求日益成長的背景下，檢體採集通訊協定如今已成為檢查室能力、供應鏈韌性和臨床工作流程的關鍵所在。

快速的技術進步、供應鏈現代化和監管協調如何重塑人們對檢體採集工作流程和臨床檢測的期望。

近年來，檢體採集領域經歷了變革性的變化，涵蓋了技術創新、操作流程重組和監管調整。新的檢測方法和檢體穩定化技術降低了分析前變異性，並進一步實現了檢測的去中心化。同時，工作流程自動化和數位化檢體追蹤加強了樣本採集與結果交付之間的協調，提高了可追溯性並縮短了周轉時間。這些變化重新定義了人們對檢體品質和可用性的期望。

近期關稅政策的變化如何促使整個檢體採集供應鏈調整策略籌資策略、供應商多元化和營運安全措施？

2025年關稅政策的變化為檢體採集耗材、醫療設備和經銷商的籌資策略引入了新的變數。這些變化透過改變接收成本和調整國內外供應商之間的競爭優勢，影響了診斷設備製造商、實驗室和經銷商的採購決策。為此，採購團隊重新評估了供應商多元化、庫存緩衝和近岸外包等方案，以確保供應的連續性並維持具有競爭力的價格結構。

從全面的細分觀點出發，探討技術模式、檢體類型、最終用戶、疾病重點領域和分銷管道如何共同決定營運重點。

深入的市場區隔揭示了不同技術、檢體類型、終端用戶、目標疾病和分銷管道之間的相互作用，從而定義了整個檢體收集領域的獨特需求和機會。依照技術分析，CLIA 和 ELISA 等免疫檢測需要特定的檢體量和處理條件，而包括數位 PCR 和即時PCR在內的 PCR 方法則要求嚴格的核酸保存和污染控制。快速檢測（無論是比色法還是側向層析法）優先考慮樣本採集的便捷性和快速穩定性，而次世代定序和 Sanger定序等定序方法則需要仔細考慮高品質的核酸萃取和監管鏈。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和基礎設施現狀正在影響各國的檢體採集策略和投資。

區域趨勢影響全球醫療衛生系統檢體採集的營運現況和策略重點。在美洲，成熟的檢查室網路和完善的公共衛生基礎設施推動了對高通量採集途徑、與集中式診斷平台整合以及自動化技術的投資，以支援廣泛的監測和臨床檢測。該區域南北差異促使人們採用混合模式，將集中式採集能力與移動採集策略相結合，以涵蓋偏遠和醫療資源匱乏的社區。

市場領導者如何將產品創新、策略夥伴關係和供應鏈韌性結合，以建立端到端的檢體採集解決方案和客戶支援模式。

主要企業在製定產品標準、推動設備設計創新以及建立檢體採集分銷管道方面發揮著至關重要的作用。市場領導者已將研發投入集中於改進檢體穩定技術、提升採集設備的人體工學設計以及增強其在不同檢測平台間的兼容性。這些企業也致力於建構完善的品管系統和法規專業知識，以支援跨境商業化並加速其在臨床檢查室和照護現場(POC) 服務提供者中的應用。

為產業領導者提供實用的策略藍圖，以整合設備創新、供應鏈韌性、法規遵循和客戶支持，從而成功採集檢體。

產業領導者應採取整合策略，將產品創新與營運效率、監管前瞻性和供應鏈穩健性結合。優先考慮模組化設備設計以及與各種檢測方法的兼容性，可加速產品在臨床和照護現場(PoC) 環境中的部署，並隨著檢測方法和平台的不斷發展而減輕檢驗負擔。對以使用者為中心的包裝、清晰的標籤檢視和培訓材料的配套投資，可提高樣本採集的準確性，減少樣本製備過程中的錯誤，並最終改善下游流程的結果。

為了確保對檢體採集實務有可靠的了解，我們採用了嚴格的混合方法研究途徑，結合了相關人員訪談、技術文獻整合和供應商檢驗。

本調查方法融合了定性和定量方法，旨在對檢體收集實踐和市場動態進行嚴謹的分析。主要研究包括對檢查室管理人員、採購負責人、臨床醫生和設備開發人員進行結構化訪談，以了解營運方面的見解和檢驗的挑戰。次要研究則整合了監管指南、技術標準和同行評審文獻，以闡明主要研究結果的背景並檢驗觀察到的趨勢。

為了維持診斷的可靠性和公共衛生影響，整合檢體採集實務、相關人員合作以及突出營運重點的結論整合至關重要。

總之，檢體採集是診斷準確性、調查有效性和公共衛生應對力的核心。技術進步、監管政策變化和區域基礎設施差異已經改變了檢體的採集、儲存和運輸方式。相關人員，最有能力提供可靠的基於檢體的檢測結果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 病毒學檢體採集市場​​檢體類型

  • 血
  • 拭子
    • 口腔黏膜拭子
    • 鼻拭子
    • 咽拭子
  • 組織
    • 福馬林固定組織
    • 新鮮冷凍組織
  • 尿

第9章：病毒學檢體採集市場：依技術分類

  • 免疫檢測
    • CLIA
    • ELISA
  • PCR
    • 數位PCR
    • 即時PCR
  • 快速檢測
    • 比色法
    • 側向流
  • 定序
    • 次世代定序
    • 桑格定序

第10章：病毒學檢體採集市場​​：依疾病類型分類

  • 肝炎
    • 甲型肝炎
    • B型肝炎
    • C型肝炎
  • HIV
  • 流感
    • 甲型流感
    • 乙型流感
  • SARS-CoV-2

第11章 病毒學檢體採集市場​​：依最終使用者分類

  • 診斷檢查室
    • 臨床檢查室
    • 參考檢測實驗室
  • 醫院
    • 私立醫院
    • 公立醫院
  • 照護端
    • 診所
    • 現場檢查基地
  • 研究機構
    • 學術機構
    • 政府機構

第12章 病毒學檢體採集市場​​：依通路分類

  • 直銷
  • 銷售代理
    • 區域銷售代理
    • 全國銷售代理
  • 線上管道
    • 企業網站
    • 第三方電子商務

第13章：病毒學檢體採集市場​​：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：病毒學檢體採集市場​​：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 病毒學檢體採集市場​​：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國病毒學檢體採集市場

第17章：中國病毒學檢體收集市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • BioFire Diagnostics LLC
  • Bionote Inc.
  • Copan Italia SpA
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • GenMark Diagnostics Inc.
  • Hardy Diagnostics
  • Hologic Inc.
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Savyon Diagnostics Ltd.
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8201ABF20F0B

The Virology Specimen Collection Market was valued at USD 4.13 billion in 2025 and is projected to grow to USD 5.14 billion in 2026, with a CAGR of 25.11%, reaching USD 19.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.13 billion
Estimated Year [2026] USD 5.14 billion
Forecast Year [2032] USD 19.82 billion
CAGR (%) 25.11%

An authoritative orientation to the technical, clinical, and operational drivers shaping modern virology specimen collection practices in healthcare systems

The landscape of virology specimen collection underpins diagnostic accuracy, research fidelity, and public health responsiveness. This introduction frames the core elements that influence specimen collection practices, encompassing technological approaches, specimen types, clinical pathways, and the end users that rely on robust sample integrity. Against a backdrop of regulatory evolution and heightened demand for rapid, reliable diagnostics, specimen collection protocols now sit at the intersection of laboratory capability, supply chain resilience, and clinical workflows.

This section outlines the major operational considerations that laboratories and healthcare providers face when collecting virology specimens. It emphasizes the importance of pre-analytical variables - from collection device selection to storage conditions - and highlights how these factors cascade into downstream assay performance. In addition, the introduction situates specimen collection within broader system-level drivers, including infection surveillance, therapeutic monitoring, and the scaling needs of point-of-care services.

By the end of this introduction, readers will have a clear orientation to the technical, logistical, and stakeholder forces shaping specimen collection practices. This foundation sets the stage for deeper analysis across technology modalities, sample types, end-user dynamics, disease focus areas, and distribution considerations that follow in subsequent sections.

How rapid technological advances, supply chain modernization, and regulatory alignment are reshaping specimen collection workflows and clinical testing expectations

The last several years have produced transformative shifts across the specimen collection landscape, spanning technological innovation, operational redesign, and regulatory adaptation. New assay formats and sample stabilization chemistries have reduced pre-analytical variability, enabling broader decentralization of testing. At the same time, workflow automation and digital sample tracking have tightened the link between collection and result delivery, improving traceability and shortening turnaround times. These changes have redefined expectations for specimen quality and availability.

Concurrently, the rise of rapid diagnostic modalities and the expansion of molecular sequencing have changed the kinds of specimens required and the conditions under which they must be collected and preserved. Point-of-care settings now demand collection devices that are robust, easy to use, and compatible with a range of assays. As a result, manufacturers and laboratories have prioritized user-centered design and interoperability. Regulatory bodies have also responded by clarifying guidance on biospecimen handling, which in turn has driven standardization across clinical and research environments.

Taken together, these shifts have created new opportunities and pressures: opportunities to extend testing to underserved settings and to integrate diagnostics into routine care pathways, and pressures to modernize supply chains, staff training, and quality systems to meet elevated expectations for specimen-driven decision making.

How recent tariff policy shifts have prompted strategic sourcing adaptations, supplier diversification, and operational safeguards across specimen collection supply chains

Tariff policy changes in 2025 introduced new variables into procurement strategies for specimen collection consumables, devices, and ancillary equipment. These changes influenced the sourcing calculus for diagnostic manufacturers, laboratories, and distributors by altering landed costs and shifting comparative advantages among domestic and international suppliers. In response, procurement teams reassessed supplier diversification, inventory buffering, and nearshoring options to preserve continuity of supply and maintain competitive pricing structures.

The cumulative effect on operational planning has been multifaceted. Laboratories re-evaluated their contracts to incorporate tariff-related clauses and to build flexibility into purchase orders. Manufacturers explored alternative component suppliers and, where feasible, localized assembly to mitigate exposure to variable duties. Distributors adjusted pricing frameworks and payment terms to reflect increased supply chain complexity, while also working with clients to optimize order cadence and reduce stockouts. Across the ecosystem, stakeholders emphasized scenario planning to understand how tariff volatility could affect lead times and product availability.

Importantly, these adjustments prioritized maintaining assay reliability and specimen integrity. Organizations adopted more rigorous validation protocols when transitioning between suppliers or materials and invested in supplier quality management to ensure that changes driven by tariff pressures did not compromise clinical or research outcomes. The overall response demonstrates how policy shifts can ripple across technical, commercial, and compliance dimensions of specimen collection.

Comprehensive segmentation-driven perspective on how technology modalities, specimen types, end users, disease focus, and distribution channels jointly determine operational priorities

Insightful segmentation reveals how different technologies, specimen types, end users, disease focuses, and distribution channels interact to define distinct needs and opportunities across the specimen collection domain. When analyzed by technology, immunoassays such as CLIA and ELISA present requirements for specific sample volumes and handling conditions, while PCR approaches including digital PCR and real-time PCR demand stringent nucleic acid preservation and contamination controls. Rapid tests, whether colorimetric assays or lateral flow formats, emphasize ease of collection and rapid stability, and sequencing modalities like next-generation sequencing and Sanger sequencing require high-quality nucleic acid extraction and chain-of-custody considerations.

Examining sample types shows divergent workflows for blood, swabs, tissue, and urine; swab subtypes including buccal, nasal, and throat collections each introduce distinct collection site protocols and transport media considerations, while tissue options such as formalin-fixed and fresh frozen formats require divergent preservation methods and processing timelines. End-user segmentation highlights operational contrasts among diagnostic laboratories, hospitals, point-of-care venues, and research institutes; clinical and reference laboratories demand standardized, high-throughput collection pipelines, private and public hospitals balance clinical throughput with patient comfort, clinics and field testing sites prioritize portability and simplicity, and academic or government research institutes often require specialized protocols for novel assays.

Disease-oriented segmentation draws attention to pathogen-specific nuances: hepatitis variants, HIV, influenza A and B, and SARS-CoV-2 each impose unique sampling windows, biosafety precautions, and stability concerns. Finally, distribution channel segmentation differentiates direct sales, distributor networks, and online platforms; local and national distributors influence logistics and lead times, while company websites and third-party e-commerce platforms reshape procurement behaviors and demand forecasting. Synthesizing these layers enables stakeholders to tailor product design, training, and supply strategies to the combination of technological and contextual requirements relevant to their operations.

Regional dynamics and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform tailored specimen collection strategies and investments

Regional dynamics shape both operational realities and strategic priorities for specimen collection across global health systems. In the Americas, established laboratory networks and expansive public health infrastructure emphasize high-throughput collection pathways, integration with centralized diagnostic platforms, and investment in automation that supports broad surveillance and clinical testing. North-south differences within the region encourage hybrid approaches that combine centralized capacity with mobile collection strategies to reach remote or underserved communities.

Across Europe, the Middle East and Africa, regulatory heterogeneity and variable infrastructure create a mosaic of specimen collection practices that emphasize adaptability. West European countries often focus on harmonized standards and interoperability, while parts of the Middle East and Africa prioritize capacity building, cold chain resiliency, and decentralized solutions that can operate reliably in constrained settings. These regional contrasts drive differentiated approaches to device design, staffing models, and training programs.

In Asia-Pacific, diverse healthcare ecosystems range from highly centralized laboratory systems in advanced economies to rapidly growing point-of-care networks in emerging markets. The region combines strong manufacturing capabilities with an appetite for innovation, producing both novel collection devices and scalable distribution models. Collectively, these regional characteristics influence procurement preferences, validation requirements, and the pace at which new specimen collection practices are adopted.

How market leaders combine product innovation, strategic partnerships, and supply chain resilience to establish end-to-end specimen collection solutions and customer support models

Leading companies play pivotal roles in defining product standards, driving innovation in device design, and shaping distribution channels for specimen collection. Market leaders have concentrated investments in research and development to improve sample stabilization chemistries, ergonomics of collection devices, and compatibility across assay platforms. These firms also focus on building robust quality systems and regulatory expertise to support cross-border commercialization and to accelerate adoption among clinical laboratories and point-of-care providers.

Beyond innovation, strategic partnerships and integrated service models have emerged as defining behaviors among successful companies. Collaborations with assay developers, diagnostics labs, and logistics providers enable end-to-end solutions that reduce barriers to adoption and ensure specimens arrive in a test-ready state. Additionally, companies that invest in training and customer support create meaningful differentiation by helping end users implement standardized collection protocols and minimize pre-analytical errors.

Competitive positioning is increasingly informed by supply chain resilience and the ability to offer modular solutions that meet diverse end-user needs. Firms that balance product breadth with focused investments in high-impact technologies and that offer flexible distribution options tend to capture sustained engagement from health systems, research institutes, and commercial laboratories.

Actionable strategic roadmap for industry leaders to synchronize device innovation, supply chain resilience, regulatory engagement, and customer enablement for specimen collection success

Industry leaders should adopt an integrated strategy that aligns product innovation with operational execution, regulatory foresight, and supply chain robustness. Prioritizing modular device design and compatibility across assay types will enable faster uptake in clinical and point-of-care settings and reduce validation burdens when assays or testing platforms evolve. Complementary investments in user-centric packaging, clear labeling, and training materials will improve collection fidelity and reduce pre-analytical errors, delivering better downstream outcomes.

Operationally, organizations should diversify supplier networks and consider regional manufacturing or assembly to mitigate tariff and logistics risks while maintaining quality oversight. Strengthening supplier qualification processes and implementing change control protocols will ensure that material substitutions do not degrade specimen integrity. Simultaneously, leaders must engage proactively with regulatory authorities to anticipate changes in specimen handling guidance and to streamline approvals for novel collection devices.

Finally, companies should expand collaborative models that bundle devices with training, digital sample tracking, and logistics services. By offering integrated solutions that lower the implementation burden for laboratories and clinics, organizations can accelerate adoption, create stickier customer relationships, and support public health initiatives that depend on reliable specimen collection.

A rigorous mixed-methods research approach combining stakeholder interviews, technical literature synthesis, and supplier validation to ensure reliable insights into specimen collection practices

The research methodology integrates qualitative and quantitative approaches to produce a rigorous analysis of specimen collection practices and market dynamics. Primary research includes structured interviews with laboratory directors, procurement professionals, clinicians, and device developers to capture operational insights and validation challenges. Secondary research synthesizes regulatory guidance, technical standards, and peer-reviewed literature to contextualize primary findings and to validate observed trends.

Data collection emphasized triangulation across sources to confirm consistency and to identify divergent practices by region, end user, and technology. Case studies and vendor due-diligence evaluations provided practical context for supply chain behaviors and product validation choices. In addition, thematic analysis of interview transcripts highlighted recurring pain points such as pre-analytical variability, cold chain constraints, and training gaps.

Finally, findings were subjected to internal peer review and methodological checks to ensure reliability. This included cross-referencing procedural descriptions with published technical standards and seeking clarification from subject matter experts when complex or conflicting information arose. The overall approach balances field-level nuance with systematic validation to inform practical recommendations.

Concluding synthesis emphasizing integrated specimen collection practices, cross-stakeholder collaboration, and operational priorities to sustain diagnostic reliability and public health impact

In conclusion, specimen collection lies at the center of diagnostic accuracy, research validity, and public health responsiveness. Technological advances, regulatory evolution, and regional infrastructure differences have collectively reshaped how specimens are collected, preserved, and transported. Stakeholders that align product design with end-user workflows, invest in supply chain resilience, and proactively engage with regulatory expectations will be best positioned to deliver reliable specimen-driven outcomes.

The synthesis presented here emphasizes the need for integrated solutions that reduce pre-analytical variability and support scalable testing across clinical, point-of-care, and research environments. By focusing on interoperability, training, and distribution flexibility, organizations can mitigate operational risks and enhance the impact of diagnostic and surveillance programs. The path forward requires ongoing collaboration among device makers, laboratories, healthcare providers, and policy makers to ensure specimen collection practices evolve in step with diagnostic innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Virology Specimen Collection Market, by Sample Type

  • 8.1. Blood
  • 8.2. Swab
    • 8.2.1. Buccal Swab
    • 8.2.2. Nasal Swab
    • 8.2.3. Throat Swab
  • 8.3. Tissue
    • 8.3.1. Formalin Fixed Tissue
    • 8.3.2. Fresh Frozen Tissue
  • 8.4. Urine

9. Virology Specimen Collection Market, by Technology

  • 9.1. Immunoassay
    • 9.1.1. CLIA
    • 9.1.2. ELISA
  • 9.2. PCR
    • 9.2.1. Digital PCR
    • 9.2.2. Real-Time PCR
  • 9.3. Rapid Test
    • 9.3.1. Colorimetric Test
    • 9.3.2. Lateral Flow
  • 9.4. Sequencing
    • 9.4.1. Next-Generation Sequencing
    • 9.4.2. Sanger Sequencing

10. Virology Specimen Collection Market, by Disease Type

  • 10.1. Hepatitis
    • 10.1.1. Hepatitis A
    • 10.1.2. Hepatitis B
    • 10.1.3. Hepatitis C
  • 10.2. HIV
  • 10.3. Influenza
    • 10.3.1. Influenza A
    • 10.3.2. Influenza B
  • 10.4. SARS-CoV-2

11. Virology Specimen Collection Market, by End User

  • 11.1. Diagnostic Laboratories
    • 11.1.1. Clinical Laboratories
    • 11.1.2. Reference Laboratories
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Point Of Care
    • 11.3.1. Clinics
    • 11.3.2. Field Testing Sites
  • 11.4. Research Institutes
    • 11.4.1. Academic Institutes
    • 11.4.2. Government Institutes

12. Virology Specimen Collection Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. Local Distributors
    • 12.2.2. National Distributors
  • 12.3. Online Channels
    • 12.3.1. Company Website
    • 12.3.2. Third-Party E-Commerce

13. Virology Specimen Collection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Virology Specimen Collection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Virology Specimen Collection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Virology Specimen Collection Market

17. China Virology Specimen Collection Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Becton, Dickinson and Company
  • 18.7. Bio-Rad Laboratories Inc.
  • 18.8. BioFire Diagnostics LLC
  • 18.9. Bionote Inc.
  • 18.10. Copan Italia S.p.A.
  • 18.11. DiaSorin S.p.A.
  • 18.12. F. Hoffmann-La Roche Ltd.
  • 18.13. GenMark Diagnostics Inc.
  • 18.14. Hardy Diagnostics
  • 18.15. Hologic Inc.
  • 18.16. Luminex Corporation
  • 18.17. Meridian Bioscience Inc.
  • 18.18. Quidel Corporation
  • 18.19. Randox Laboratories Ltd.
  • 18.20. Savyon Diagnostics Ltd.
  • 18.21. Seegene Inc.
  • 18.22. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BUCCAL SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FORMALIN FIXED TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FRESH FROZEN TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COLORIMETRIC TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS A, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS B, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS C, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HIV, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA A, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA B, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SARS-COV-2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY FIELD TESTING SITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HEPATITIS, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY INFLUENZA, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA VIROLOGY SPECIMEN CO